FDA 483 - OneBlood, Inc. - March 21, 2023

An FDA inspection of OneBlood, Inc. in Pensacola, FL, identified a critical failure in equipment maintenance and quality control. The firm did not perform scheduled cleaning and maintenance on blood collection equipment as required by their SOPs, nor did management review the associated maintenance logs, indicating a significant deviation from established procedures.